Newsroom
Sorted by: Latest
-
Sumitomo Biorational Company Names Remy Lyczko As President, AgroSolutions Division
LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Sumitomo Biorational Company LLC today announced the appointment of Remy Lyczko as President of its AgroSolutions Division (ASD), effective July 1, 2026. In this role, Lyczko will lead the division responsible for developing innovative biorational and botanical technologies that help growers improve productivity while advancing more sustainable agricultural systems. Under his leadership, the division will continue to expand solutions that support modern farm...
-
PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors that Eric Benjamin, Insulet Corporation's (NASDAQ: PODD) former Executive Vice President and Chief Operating Officer, is named as a defendant in a securities class action alleging he made false statements about Omnipod product safety while selling $3.7 million in company stock during the Class Period. Find out if you can recover losses tied to executive misconduct. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsi...
-
Varicent Named a Leader in the 2026 Gartner® Magic Quadrant™ for Sales Performance Management
TORONTO--(BUSINESS WIRE)--Varicent Named a Leader in the 2026 Gartner® Magic Quadrant™ for Sales Performance Management...
-
Avia Equities, LLC Acquires 190 Unit Blair at Bitters Multifamily Community in San Antonio, Texas
SAN ANTONIO--(BUSINESS WIRE)--Avia Equities, LLC ("Avia") announced that it has acquired Blair at Bitters, a 190 unit garden style multifamily community located in San Antonio, Texas. The acquisition of Blair at Bitters represents a strategic expansion of Avia’s footprint in Central Texas and aligns with the firm’s focus on well located, attainable housing in high growth markets. The business plan includes targeted interior and exterior renovations, and upgrades to common areas and amenities, w...
-
TD SYNNEX Included in TIME America’s Best Companies 2026 List
CLEARWATER, Fla. & FREMONT, Calif.--(BUSINESS WIRE)--TD SYNNEX (NYSE: SNX) has been recognized on TIME’s list of America’s Best Companies 2026....
-
LEO Pharma Announces Key Results of Phase 2 TRAPEDS-1 Trial Evaluating Pharmacokinetics and Safety of Tralokinumab in Children With Moderate-to-Severe Atopic Dermatitis
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab...
-
Mechanical Orchard Releases Imogen Platform Improvements
SAN FRANCISCO--(BUSINESS WIRE)--Mechanical Orchard's latest release cuts the risk and timeline of mainframe modernization, making it affordable to replace aging critical systems....
-
Helios Technologies Named to TIME’s 2026 America’s Best Companies List
SARASOTA, Fla.--(BUSINESS WIRE)--Helios Technologies, Inc. (NYSE: HLIO) Named to TIME’s 2026 America’s Best Companies List...
-
Keysight Delivers New High-Performance 4x100GE Network Cybersecurity Test Platform
SANTA ROSA, Calif.--(BUSINESS WIRE)--Scalable 4x100GE test solution provides hyperscale traffic generation and cybersecurity validation in a compact 1 rack unit footprint....
-
OpenEvidence and NewYork-Presbyterian, Columbia University and Weill Cornell Medicine Expand Clinical AI Tools Across New York City and Westchester
MIAMI & NEW YORK--(BUSINESS WIRE)--OpenEvidence, a medical AI and clinical decision support tool for U.S. clinicians, today announced a collaboration with NewYork-Presbyterian and its affiliated medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, to deploy OpenEvidence across all hospitals and care sites throughout the Greater New York region. This enterprise-scale collaboration will place trusted, evidence-based clinical AI in the hands o...